Ariadne Wealth Management, LP Bristol Myers Squibb CO Transaction History
Ariadne Wealth Management, LP
- $223 Billion
- Q3 2025
A detailed history of Ariadne Wealth Management, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ariadne Wealth Management, LP holds 8,072 shares of BMY stock, worth $377,850. This represents 0.18% of its overall portfolio holdings.
Number of Shares
8,072
Previous 6,872
17.46%
Holding current value
$377,850
Previous $329 Million
19.38%
% of portfolio
0.18%
Previous 0.16%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,679Shares Held
1.58BCall Options Held
28.2MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...